ClinicalTrials.gg
Not yet recruitingNCT07808463Updated Sep 8, 2026

Prospective Paired Evaluation of Conventional Versus Structured Magnetic Resonance Imaging Interpretation for Preoperative Assessment of Gluteal Permanent Synthetic Filler Disease

An observational study in Foreign-Body Reaction, Soft Tissue Filler Complication and Gluteal Permanent Synthetic Filler Disease, sponsored by Research Inc. Not yet recruiting. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2026-09-08.

Sponsored by Research Inc · Observational

Study type
Observational
Model
Other
Time perspective
Prospective
Enrollment
200
Ages
18 Years and older
Sex
All
01

Study summary

This prospective paired diagnostic-impact study will compare conventional qualitative MRI reporting with a new structured anatomic classification in adults undergoing surgery for gluteal permanent synthetic filler disease. The structured report will document material effects across superficial, deep, muscular, regional, lymphatic, and interstitial compartments. Standardized intraoperative mapping will serve as the reference standard. The main outcome is the difference in sensitivity for surgically confirmed compartment involvement

Read the detailed description

Eligible participants will undergo a standardized pelvic and gluteal MRI before planned filler-removal surgery. The same examination will be interpreted using two prespecified formats: a conventional qualitative report and a structured report that grades involvement of the fat-fascia interface, subcutaneous fat, deep fascia, gluteal muscles, subcrestal, ischial, trochanteric, and pelvic-ring regions, as well as lymphatic and interstitial pathways. The operating surgeon will record a preliminary plan and utility rating after each report. During surgery, actual compartment involvement will be documented using a standardized map and, when available, specimen and histopathologic findings. Paired diagnostic performance, inter-reader agreement, change in surgical planning, and associations with operative complexity will be analyzed.

02

Conditions studied

  • Foreign-Body Reaction
  • Soft Tissue Filler Complication
  • Gluteal Permanent Synthetic Filler Disease

Keywords

  • Biopolymers
  • Permanent Synthetic Fillers
  • Magnetic Resonance Imaging
  • Structured Reporting
  • Preoperative Planning
  • Gluteal Region
03

In context

Lead sponsor

Research Inc is the lead sponsor of 24 studies on the registry; 22 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Adults with prior gluteal injection of permanent synthetic fillers who undergo preoperative pelvic/gluteal MRI and are scheduled for surgical removal or exploration.

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Age 18 years or older.
  • History of gluteal injection with a permanent or unknown nonresorbable filler.
  • Preoperative pelvic/gluteal MRI performed using the study acquisition protocol.
  • Planned surgical removal, , or operative exploration within 90 days after MRI.
  • Written for paired image interpretation and use of operative findings.

Exclusion criteria

Exclusion Criteria:

  • MRI or nondiagnostic imaging caused by motion or incomplete anatomic coverage.
  • Prior extensive gluteal filler removal that prevents mapping of the predefined compartments.
  • No operative procedure within 90 days after MRI and therefore no reference-standard assessment.
  • Acute life-threatening infection or emergency surgery that prevents completion of the preoperative reporting sequence.
  • Inability to provide consent.
Terms in these criteria, in plain language(3)

Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.

Biopsy and archival tissue

A biopsy takes a small piece of tissue to examine. “Archival tissue” is a sample already taken, for example at diagnosis, and kept by the hospital.

Whether a stored sample will do depends on when it was taken, how much there is and what the study needs. Ask whether the study accepts your stored sample or needs a new biopsy.

Informed consent

Before you join, the study team explains what taking part involves — its purpose, what happens, the risks and possible benefits — and answers your questions, so you can decide freely. Consent is usually recorded on a form (the informed consent form, ICF) signed by you or, where the law allows, by someone legally authorised to decide for you.

You can keep asking questions during the study, you are told of new information that matters, and you can choose to leave at any time.

Contraindication

A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.

05

Study design

Observational model
Other
Time perspective
Prospective
Enrollment
200 participants (estimated)
Target follow-up
1 Day
Patient registry
Yes

Groups and cohorts

  • Paired MRI Interpretation Cohort

    Each participant has the same MRI interpreted with the conventional qualitative format and with the structured anatomic classification before the index operation.

    Diagnostic Test: Conventional Qualitative MRI Interpretation · Diagnostic Test: Structured Gluteal Filler MRI Classification · Procedure: Standardized Intraoperative Anatomic Mapping

Interventions

  • Diagnostic testConventional Qualitative MRI Interpretation

    The report records the presence or absence of injected foreign material in the gluteal region and any routinely reported findings. A preliminary surgical plan is recorded after review of this report. Linked arm/group(s): Paired MRI Interpretation Cohort.

  • Diagnostic testStructured Gluteal Filler MRI Classification

    The report records material distribution and severity in predefined compartments: fat-fascia interface, subcutaneous fat, deep fascia, gluteal muscles, subcrestal region, ischial region, trochanteric region, pelvic ring, lymphatic pathways, and interstitial involvement. The final classification manual and grade definitions will be locked before enrollment. Linked arm/group(s): Paired MRI Interpretation Cohort.

  • ProcedureStandardized Intraoperative Anatomic Mapping

    During the index operation, the surgeon documents actual involvement of each predefined compartment before reviewing the imaging accuracy analysis. Operative photographs, specimen mapping, and histopathology may support the reference standard. Linked arm/group(s): Paired MRI Interpretation Cohort.

06

What researchers measure

Primary outcomes

  1. Sensitivity for Surgically Confirmed Anatomic Compartment Involvement

    For each reporting method, sensitivity is the number of predefined compartments identified as involved on MRI divided by the number confirmed as involved during standardized intraoperative mapping. The structured and conventional results will be compared within the same participant.

    Time frame: Preoperative MRI interpretation and the index surgical procedure performed within 90 days after MRI. 90 days

Secondary outcomes

  1. Specificity for Surgically Uninvolved Anatomic Compartments

    For each method, specificity is the number of compartments correctly identified as uninvolved on MRI divided by the number documented as uninvolved at surgery.

    Time frame: Preoperative MRI interpretation and the index surgical procedure performed within 90 days after MRI. 90 dys

  2. Change in Preoperative Surgical Plan After Structured MRI Review

    Proportion of participants for whom the recorded operative plan changes after the structured report, including planned incision, extent of excision, anticipated deep-plane dissection, lymphatic evaluation, or reconstruction strategy.

    Time frame: Immediately after the conventional report and immediately after the structured report, both before surgery. 1 day

  3. Surgeon-Rated MRI Report Utility

    The operating surgeon rates completeness, anatomic clarity, confidence, and usefulness for planning on prespecified 0-to-10 scales after each report. Higher scores indicate greater perceived utility.

    Time frame: Immediately after review of each preoperative MRI report. 1 day

07

Study locations

No study locations are listed for this record.

08

References and documents

Publications

  • Osorio E, Ramirez B, Herrera O, Suarez C, Ciro C, Varela A. Three-flap Technique: Comprehensive Approach for Biopolymer Removal in the Gluteal and Lumbar Regions. Plast Reconstr Surg Glob Open. 2026 Jul 23;14(7):e7870. doi: 10.1097/GOX.0000000000007870. eCollection 2026 Jul. PubMed 42495057 ↗
  • Yahyavi-Firouz-Abadi N, Menias CO, Bhalla S, Siegel C, Gayer G, Katz DS. Imaging of cosmetic plastic procedures and implants in the body and their potential complications. AJR Am J Roentgenol. 2015 Apr;204(4):707-15. doi: 10.2214/AJR.14.13516. PubMed 25794060 ↗
  • Niasme E, Delattre BMA, Lenoir V, Modarressi A, Poletti PA, Becker M, Boudabbous S. Quantitative magnetic resonance imaging: differentiating soft tissue implants and fillers used in cosmetic and reconstructive surgery. Skeletal Radiol. 2021 Jan;50(1):231-237. doi: 10.1007/s00256-020-03564-z. Epub 2020 Aug 5. PubMed 32761256 ↗
  • Soliman SB. Liquid silicone filler migration following illicit gluteal augmentation. Radiol Case Rep. 2023 Jan 5;18(3):984-990. doi: 10.1016/j.radcr.2022.12.049. eCollection 2023 Mar. PubMed 36636483 ↗
  • Leyva A, Tran T, Cibulas AT, Warden D, Danger FJ, Scherer K, Wasyliw C. Filler Migration and Granuloma Formation After Gluteal Augmentation with Free-silicone Injections. Cureus. 2018 Sep 13;10(9):e3294. doi: 10.7759/cureus.3294. PubMed 30443464 ↗

Individual participant data

Plan to share: No — no, due the privacity and informed consents signed by the patients

09

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Start is estimated for Oct 2026; primary completion for Dec 2026, 2 months later.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 1, 2026
First posted
Sep 8, 2026
StartEst.
Oct 1, 2026
Primary completionEst.
Dec 1, 2026
CompletionEst.
Dec 31, 2026
Last update
Sep 8, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Sep 8, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07808463
Lead sponsor
Research Inc
Responsible party
Sponsor
First posted
Sep 8, 2026
Start date
Oct 1, 2026 (estimated)
Primary completion
Dec 1, 2026 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Sep 8, 2026

Study contacts

Edison Osorio, MD, Plastic surgeon
Contact
info@edisonosorio.com
+573226140611
Edison Osorio, MD, plastic surgery
principal investigator

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is not yet recruiting, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion